Capitalizing on New Opportunities for Stem Cell Products

Market Size and Share and Market Growth Potential

• Estimated market share for stem cell research products by market segment and geographic region
• Estimated market share of top suppliers by stem cell research product category (i.e., media, sera, supplements, and cells)
• Projected growth of stem cell research products market by market segment and geographic region
• Anticipated stem cell research budgets for 2009 by market segment and geographic region
• Expected change in spending on stem cell products and cell lines over the next two to three years (through 2011)

Frequently Asked Questions (related to):

• Products needed to support scientists' current stem cell research
• Cell types and disease that are/will be the focus of stem cell research
• Use of embryonic versus induced pluripotent cells for specific applications
• Unmet product needs and product differentiation strategies
• New product and/or service development opportunities
• Best channels by which to communicate with and market to stem cell researchers

• Objectives
• Questionnaire design
• Survey population

Research Overview and Applications

• Length of time conducting research
• Goals of stem cell research
• Features of stem cells studied
• Source, type, and number of different stem cell lines used in 2008
• Source, type, and number of different stem cell lines expected to be used in 2009
• Source and type of stem cell lines plan to use two to three years from now (2010 and 2011)
• Impact on research of lifting US restrictions on federal funding of embryonic stem cells
• Differentiated cell types that were/are/will be the focus of stem cell research for 2008, 2009, and two to three years from now (2010 and 2011)
• Diseases that are the focus of stem cell research by type of stem cell
• Top scientific journals respondents rate as most critical to their stem cell research
• Critical stem cell conferences

Stem Cell Culture Products: Top Suppliers and Budgets

• Suppliers from whom respondents purchase stem cell culture products
• Percent of stem cell culture product purchases made from leading suppliers
• Estimated 2008 budget for stem cell culture products
• Percent of 2008 budget spent on stem cell media, sera, and supplements
• Estimated 2009 budget that will be dedicated to stem cell culture products and stem cell lines
• Percent of 2009 budget that will be spent on stem cell media, sera, and supplements
• Expected change in expenditures on stem cell media, sera, and supplements over the next two to three years (2010 and 2011)

Stem Cell Media: Usage, Product Features and Special Requirements

• Types of media used to grow and culture stem cells
• Percent of media that is custom vs. off-the-shelf
• Estimate of stem cell culture media used per month in 2008
• Estimate of stem cell culture media expected to be used per month in 2009
• Expected change in stem cell culture media usage for two to three years from now (2010 and 2011)
• Importance of xeno-free and animal-free types of stem cell culture media
• Advantages of stem cell culture media from primary supplier
• Satisfaction with features of stem cell culture media from primary supplier
• Requirements for GMP conditions for stem cell culture products

Stem Cells: Sources, Budgets, and Special Requirements

• General sources from which respondents acquire stem cells
• Percent of stem cell purchases made from major sources in 2008
• Percent of stem cell purchases expected to be made from major sources in 2009
• Expected changes in the percent of stem cell purchases expected to be made from commercial suppliers over the next two to three years (2010 and 2011)
• Commercial suppliers and/or national bank/repositories from which respondents currently purchase stem cells
• Percent of stem cell purchases made from commercial suppliers and/or national bank/repositories
• Estimated 2008 budget for stem cell lines
• Estimated 2009 budget that will be dedicated to stem cell lines
• Reasons why respondents acquire stem cells from their primary suppliers
• Percent of stem cells grown on feeders and sources of feeder cells
• Use of 3-D cell culture in stem cell research
• Reasons for interest in 3-D cell culture for stem cell research

Supporting Products, Technologies, and Services

• Techniques respondents use to identify differentiated cell types derived from stem cells
• Major disadvantages of techniques used to identify differentiated cell types derived from stem cells
• Primary supplier of consumable products used to perform techniques for identifying differentiated cell types derived from stem cells
• Stem cell-specific kits or panels currently used and planned to use in the next 12 months
• Stages of stem cell workflow processes with which respondents are involved
• Stage of stem cell workflow that respondents would most like a new product/technology to facilitate their research
• Types of stem cell-related services that respondents would be most interested in obtaining from suppliers
• .

Additional Analysis by:

• Market segment
• Geographic region
• Years of experience
• Stem cell type
• Research focus
• Lab size

Appendix A. Respondents Planning to Conduct Stem Cell Research

• Time frame that respondents plan to begin stem cell research
• Sources of funding that will support future stem cell research
• Anticipated annual budget for stem cell culture products and stem cell lines
• Sources and types of stem cells respondents plan to use in their research
• Differentiated cell types that will be the focus of stem cell research
• Diseases that will be the focus of stem cell research by cell type
• Sources from which respondents plan to acquire stem cells

Appendix B. Verbatim Responses to Questions

• Do you think your stem cell research will change due to the lifting of US restrictions on federal funding for human embryonic stem cell research by the new presidential administration? Why or why not?
• Like many stem cell pioneers, Ian Wilmut, the creator of Dolly the sheep, has embraced an alternative approach. Are induced pluripotent stem cells the beginning of the end for embryonic cloning? Why or why not?